Noventure
Noventure is a Barcelona-based startup specializing in licensing medical devices and food supplements based on natural polymers and proprietary barrier technology. They focus on areas such as gastrointestinal, pediatrics, urogynaecology, allergy, and dermatology, aiming to build long-term partnerships worldwide. Their products are distributed in more than 45 countries, and they emphasize innovation, collaboration, and long-lasting relationships.
Industries
Nr. of Employees
small (1-50)
Noventure
Avda. Diagonal 549, 5ª planta, 08029 Barcelona, Spain
Products
Hydrogel wound dressing containing Olea europaea leaf extract (amorphous hydrogel)
Amorphous hydrogel formulation combining polysaccharide moisturizers and botanical antioxidant extracts intended to support healing of partial- and full-thickness skin ulcers by modulating wound-bed pH and providing barrier moisture.
Oral capsule formulation delivering a non-pharmacological intestinal barrier agent for urinary tract infection control
Oral capsule formulation using a film-forming mucoprotectant intended to act in the intestine to reduce invasion by uropathogenic bacteria and support control/prevention of uncomplicated UTIs.
Mucomimetic intranasal spray using film-forming hemicellulose
Intranasal spray formulation based on hemicellulose-derived mucomimetic agents designed to form a protective barrier over nasal epithelium and support symptomatic control of rhinitis and rhinosinusitis.
Gel oral rehydration solution (ORS) formulations
Gel or semi-solid oral rehydration formulations developed to improve palatability, reduce administered volume and aid acceptability in pediatric acute diarrhea management.
Hydrogel wound dressing containing Olea europaea leaf extract (amorphous hydrogel)
Amorphous hydrogel formulation combining polysaccharide moisturizers and botanical antioxidant extracts intended to support healing of partial- and full-thickness skin ulcers by modulating wound-bed pH and providing barrier moisture.
Oral capsule formulation delivering a non-pharmacological intestinal barrier agent for urinary tract infection control
Oral capsule formulation using a film-forming mucoprotectant intended to act in the intestine to reduce invasion by uropathogenic bacteria and support control/prevention of uncomplicated UTIs.
Mucomimetic intranasal spray using film-forming hemicellulose
Intranasal spray formulation based on hemicellulose-derived mucomimetic agents designed to form a protective barrier over nasal epithelium and support symptomatic control of rhinitis and rhinosinusitis.
Gel oral rehydration solution (ORS) formulations
Gel or semi-solid oral rehydration formulations developed to improve palatability, reduce administered volume and aid acceptability in pediatric acute diarrhea management.
Services
Provides exclusive regional licensing arrangements and supports commercialization through partner selection, contract negotiation and handover of regulatory/commercial documentation.
Collaborates with external organizations to bring science assets to market via licensing-out and co-development tailored to partner commercial capabilities.
Offers market intelligence, project management and business development services to support partner launch planning and market access.
Provides exclusive regional licensing arrangements and supports commercialization through partner selection, contract negotiation and handover of regulatory/commercial documentation.
Collaborates with external organizations to bring science assets to market via licensing-out and co-development tailored to partner commercial capabilities.
Offers market intelligence, project management and business development services to support partner launch planning and market access.
Expertise Areas
- Medical device licensing and commercialization
- Regulatory compliance for medical devices (CE, ISO 13485)
- Hydrogel and topical formulation development
- Natural polymer barrier technologies and mucoprotectants
Key Technologies
- Hydrogel formulation
- Natural polymer film-forming barrier systems (e.g., xyloglucan, gelatin tannate)
- Mucomimetic intranasal formulations
- Oral capsule formulations for non-pharmacological devices
News & Updates
Noventure will attend the CPHI 2025 in Frankfurt, 28-30 October 2025. Arrange a meeting to learn more about their products and license availability.
Noventure will attend EuroPLX 83 in Vienna, Austria, 25-26 September 2023. Arrange a meeting to learn more about their products and license availability.
Noventure participated at the third edition of FNM in Amsterdam, 29 August to 1 September 2018, presenting Gelsectan® for IBS-D and hosting a meeting with European thought leaders.
A study on Rhinosectan® spray containing xyloglucan and its effects on nasal ciliary function was published, showing it does not impair ciliary movement and enhances mucociliary clearance.
A study on the antioxidant and wound-healing properties of EHO-85 hydrogel containing Olea europaea leaf extract was published, showing its protective role against oxidative stress and its efficacy in wound healing.
A review of UTIs in the elderly, risk factors, and non-antimicrobial treatment options including Utipro Plus®, a medical device that acts in the intestine as a mechanical barrier against uropathogenic E. coli strains.
Noventure will attend the CPHI 2025 in Frankfurt, 28-30 October 2025. Arrange a meeting to learn more about their products and license availability.
Noventure will attend EuroPLX 83 in Vienna, Austria, 25-26 September 2023. Arrange a meeting to learn more about their products and license availability.
Noventure participated at the third edition of FNM in Amsterdam, 29 August to 1 September 2018, presenting Gelsectan® for IBS-D and hosting a meeting with European thought leaders.
A study on Rhinosectan® spray containing xyloglucan and its effects on nasal ciliary function was published, showing it does not impair ciliary movement and enhances mucociliary clearance.
A study on the antioxidant and wound-healing properties of EHO-85 hydrogel containing Olea europaea leaf extract was published, showing its protective role against oxidative stress and its efficacy in wound healing.
A review of UTIs in the elderly, risk factors, and non-antimicrobial treatment options including Utipro Plus®, a medical device that acts in the intestine as a mechanical barrier against uropathogenic E. coli strains.